---
figid: PMC3825728__onci-2-e25853-g1
figtitle: BTLA, a key regulator of VG9VD2 T-cell proliferation
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
pmcid: PMC3825728
filename: onci-2-e25853-g1.jpg
figlink: /pmc/articles/PMC3825728/figure/F1/
number: F1
caption: Figure 1. Lymphoma cells may regulate intranodal Vγ9Vδ2 T-cell expansion
  via a BTLA- and HVEM-dependent signaling pathway. (A) Isopentenyl pyrophosphate
  (IPP) produced by cancer cells can be recognized by the Vγ9Vδ2 T-cell receptor (TCR),
  hence stimulating Vγ9Vδ2 T-cell proliferation. Lymphoma cells expressing the herpesvirus
  entry mediator A (HVEM) inhibit the trasnduction of Vγ9Vδ2 TCR-elicited signals
  by interacting with B and T lymphocyte associated (BTLA), hence impeding Vγ9Vδ2
  T-cell proliferation. (B) Monoclonal antibodies directed against BTLA or HVEM allow
  Vγ9Vδ2 T cells to proliferate in spite of the presence of HVEM+ lymphoma cells.
papertitle: BTLA, a key regulator of Vγ9Vδ2 T-cell proliferation.
reftext: Julie Gertner-Dardenne, et al. Oncoimmunology. 2013 Sep 1;2(9):e25853.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8110549
figid_alias: PMC3825728__F1
figtype: Figure
redirect_from: /figures/PMC3825728__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3825728__onci-2-e25853-g1.html
  '@type': Dataset
  description: Figure 1. Lymphoma cells may regulate intranodal Vγ9Vδ2 T-cell expansion
    via a BTLA- and HVEM-dependent signaling pathway. (A) Isopentenyl pyrophosphate
    (IPP) produced by cancer cells can be recognized by the Vγ9Vδ2 T-cell receptor
    (TCR), hence stimulating Vγ9Vδ2 T-cell proliferation. Lymphoma cells expressing
    the herpesvirus entry mediator A (HVEM) inhibit the trasnduction of Vγ9Vδ2 TCR-elicited
    signals by interacting with B and T lymphocyte associated (BTLA), hence impeding
    Vγ9Vδ2 T-cell proliferation. (B) Monoclonal antibodies directed against BTLA or
    HVEM allow Vγ9Vδ2 T cells to proliferate in spite of the presence of HVEM+ lymphoma
    cells.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Ipp
  - CG9784
  - CG9426
  - CG6805
  - Synj
  - INPP5E
  - 5PtaseI
  - mab
  - Tcr
---
